Skip to content
Therapeutic Areas
Oncology
Gastroenterology (GI)
Hematology
Cell and Gene Therapy
Neurology
Infectious Diseases
Radiopharmaceuticals
Respiratory
Other TAs
Insights
Global Reach
About PSI
About Us
Newsroom
Careers
Therapeutic Areas
Oncology
Gastroenterology (GI)
Hematology
Cell and Gene Therapy
Neurology
Infectious Diseases
Radiopharmaceuticals
Respiratory
Other TAs
Insights
Global Reach
About PSI
About Us
Newsroom
Careers
Contact
Submit RFP
Search
Category: Congress Highlights
The shift towards precision medicine in hematology: Five sponsor takeaways from EHA 2026
Radiopharmaceutical advances expose the need for specialized trial support
Practice-changing progress and decisive oncology breakthroughs
The precision era in respiratory medicine
Advances in IBD treatment considerations, GI trial design, and the impact of AI
Developments in sepsis, antimicrobial resistance, antifungals, and immunotherapies
Blood biomarkers, combination therapies, and AI co-scientists: AD/PD 2026 signals for sponsors
Holistic care in IBD: Maturing from concept to practice
Radical acceleration: AI in clinical trials
«
Page
1
Page
2
Page
3
»
Therapeutic Areas
Oncology
Gastroenterology (GI)
Hematology
Cell and Gene Therapy
Neurology
Infectious Diseases
Radiopharmaceuticals
Respiratory
Other Therapeutic Areas
Insights
Global Reach
VISIONAL™ by PSI
SYNETIC™ by PSI
Industry Events
Careers
About PSI
About Us
Newsroom
Contact Us
Submit RFP
